射血分数降低的心力衰竭药物治疗的顺序安排
本文综述了射血分数降低的心力衰竭(HFrEF)中疾病修饰药物疗法的证据,探讨了同时快速启动这些治疗与按试验顺序给药的策略。文章强调需关注时间定义的滴定目标、患者个体化,并提出心衰门诊滴定方案和实用治疗评分以克服治疗惰性。
要点
- HFrEF有多种延长生命的药物,但延迟治疗带来可避免的死亡风险。
- 传统按试验顺序给药,新策略支持同时快速启动并设定时间限定目标。
- 需充足人员(心衰专科护士和药师)及治疗评分来克服治疗惰性。
核心结论
- 同时快速启动HFrEF疾病修饰药物并设定时间定义的滴定目标,可能减少延迟治疗带来的可避免死亡风险。
研究设计与样本
- 本文为综述,基于随机临床试验证据,讨论HFrEF药物治疗的顺序安排策略。
主要发现
- HFrEF疾病修饰药物可改善症状和生存,但延迟治疗存在潜在可避免的死亡风险。
- 传统按临床试验时间顺序给药,而同时快速启动策略可能更优。
- 提出心衰门诊滴定方案和实用治疗评分以评估最佳药物治疗的达成。
临床怎么用
- 临床医生应考虑同时快速启动HFrEF药物,并设定时间限定的滴定目标。
- 应用治疗评分在每次接触时评估最佳药物治疗的达成,以克服治疗惰性。
- 确保充足的心衰专科护士和药师配备以提供该护理能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The management of heart failure with a reduced ejection fraction is a true success story of modern medicine. Evidence from randomised clinical trials provides the basis for an extensive catalogue of disease-modifying drug treatments that improve both symptoms and survival. These treatments have undergone rigorous scrutiny by licensing and guideline development bodies to make them eligible for clinical use. With an increasing number of drug therapies however, it has become a complex management challenge to ensure patients receive these treatments in a timely fashion and at recommended doses. The tragedy is that, for a condition with many life-prolonging drug therapies, there remains a potentially avoidable mortality risk associated with delayed treatment. Heart failure therapeutic agents have conventionally been administered to patients in the chronological order they were tested in clinical trials, in line with the aggregate benefit observed when added to existing background treatment. We review the evidence for simultaneous expedited initiation of these disease-modifying drug therapies and how these strategies may focus the heart failure clinician on a time-defined smart goal of drug titration, while catering for patient individuality. We highlight the need for adequate staffing levels, especially heart failure nurse specialists and pharmacists, in a structure to provide the capacity to deliver this care. Finally, we propose a heart failure clinic titration schedule and novel practical treatment score which, if applied at each heart failure patient contact, could tackle treatment inertia by a constant assessment of attainment of optimal medical therapy.
引用
- Savage, Dimarco, Li, et al. Sequencing of medical therapy in heart failure with a reduced ejection fraction. Heart. 2023. PMID: 36368882. doi:10.1136/heartjnl-2022-321497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。